CSF profiling of the human brain enriched proteome reveals associations of neuromodulin and neurogranin to Alzheimer's disease
Julia Remnestål(Science for Life Laboratory), Anna Månberg(Science for Life Laboratory), Lars Lannfelt(BioArctic Neuroscience (Sweden)), Kaj Blennow(Sahlgrenska University Hospital), Jochen M. Schwenk(Science for Life Laboratory), Claudia Fredolini(Science for Life Laboratory), Per Svenningsson(Karolinska Institutet), Nicholas Mitsios(Karolinska Institutet), Bengt Nellgård(Sahlgrenska University Hospital), Mathias Uhlén(Science for Life Laboratory), Kim Kultima(Uppsala University), Henrik Zetterberg(University of Wisconsin–Madison), Peter Nilsson(Science for Life Laboratory), David Just(Science for Life Laboratory), Martin Ingelsson(Uppsala University), Lena Kilander(British Geriatrics Society), Jan Mulder(Karolinska Institutet)
Cited by 114
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
|New England Journal of Medicine|2014|2k
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k